# Divergent Roles of HIF-1α and HIF-2α in Embryonic Development and Early Pregnancy

## TL;DR

This paper explores how HIF-1α and HIF-2α have different roles in early pregnancy and embryonic development, impacting reproductive success and potential therapies.

## Contribution

The study reveals distinct functions of HIF-1α and HIF-2α in maternal and embryonic processes during early pregnancy.

## Key findings

- HIF-1α is crucial for early embryonic development and maternal metabolic adaptation.
- HIF-2α regulates later developmental stages and processes like implantation and trophoblast invasion.
- Disruption of either HIF isoform leads to reproductive defects and pregnancy disorders.

## Abstract

Physiological hypoxia is a defining feature of early pregnancy, coordinating menstrual repair, implantation, decidualization, placental development, and fetoplacental adaptation. Hypoxia-inducible factors, HIF-1α and HIF-2α, act as master regulators of these processes by sensing oxygen tension and orchestrating cellular responses in metabolism, angiogenesis, immune regulation, and tissue remodeling. Although structurally related, HIF-1α and HIF-2α exhibit distinct spatial and temporal functions across reproductive stages. Embryonic HIF-1α is primarily involved in early embryonic development, whereas embryonic HIF-2α is required for later developmental stages. Furthermore, maternal HIF-1α acts early in pregnancy, coordinating metabolic adaptation, endometrial regeneration, decidualization, angiogenic expansion, placental organization, and maternal immune tolerance. In contrast, maternal HIF-2α regulates epithelial breakdown, trophoblast invasion, implantation mechanics, and vesicle-mediated trafficking. Mouse genetics demonstrate that disruption of either isoform leads to non-redundant defects in reproductive success, from failed implantation to placental insufficiency and fetal lethality. Pathological hypoxia or aberrant HIF signaling drives pregnancy disorders including preeclampsia, fetal growth restriction, recurrent pregnancy loss, and heavy menstrual bleeding. Defining the distinct roles of HIF-1α and HIF-2α supports the development of therapies targeting hypoxia-responsive pathways in infertility and obstetric disease.